Development of replication-competent viral vectors for HIV vaccine delivery. - Wikidata - awgldk - TriplyDB

Development of replication-competent viral vectors for HIV vaccine delivery.

Development of replication-competent viral vectors for HIV vaccine delivery.

http://www.wikidata.org/entity/Q33694226

about

HIV-1 prophylactic vaccines: state of the art Mechanisms of HIV protein degradation into epitopes: implications for vaccine design HIV-1 vaccines: challenges and new perspectives Clonotypic composition of the CD4+ T cell response to a vectored retroviral antigen is determined by its speed.A novel, live-attenuated vesicular stomatitis virus vector displaying conformationally intact, functional HIV-1 envelope trimers that elicits potent cellular and humoral responses in mice.Architectural insight into inovirus-associated vectors (IAVs) and development of IAV-based vaccines inducing humoral and cellular responses: implications in HIV-1 vaccines Vaccines that stimulate T cell immunity to HIV-1: the next step A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG).Attenuation of Replication-Competent Adenovirus Serotype 26 Vaccines by Vectorization New prospects for a preventive HIV-1 vaccine.Live virus vaccines based on a yellow fever vaccine backbone: standardized template with key considerations for a risk/benefit assessment Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies Profiling the neutralizing antibody response in chronically HIV-1 CRF07_BC-infected intravenous drug users naïve to antiretroviral therapy.Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccines.HIV vaccines: a brief overview.The alien replicon: Artificial genetic constructs to direct the synthesis of transmissible self-replicating RNAs: In vivo synthesised heterologous (alien) RNA constructs are capable of initiating self-replication following transmission to the host o Development of a recombinant yellow fever vector expressing a HIV clade C founder envelope gp120.Development of an epitope-based HIV-1 vaccine strategy from HIV-1 lipopeptide to dendritic-based vaccines.Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment.Novel Concepts for HIV Vaccine Vector Design.Induction of genotype-cross reactive, hepatitis C virus-specific cell mediated immunity in DNA-vaccinated mice.

P2860

Q26740042-3C08B64A-65B3-48C8-ACA6-F9FB92490BBE Q26866505-CAAD004D-7C2F-4E4C-8918-6CAB8B6C9266 Q33577972-4F9C4B02-CD93-4FA0-88EF-73BF48FDACEA Q33993393-9B9E202C-F1F0-406E-9817-25C23E82BD34 Q34172295-C7F0EB13-5B62-4211-831A-262C95D3BA06 Q34774808-E434B1BF-D8B0-4790-AC63-F6A223C5F251 Q35073079-F029DECF-E92C-4D2A-980C-39EFCB1D4654 Q35861251-A8C0585B-9EFA-44CB-850E-E1E6DD8C81E5 Q36057541-9E3B48B3-E0F4-4CCE-BECF-B35F6F773E00 Q36211653-75A0C73C-D0C0-415D-A580-C3688A453E4D Q36223864-DB9167CF-61EB-4199-8952-D01DC931A247 Q36307457-91E1B61F-AC8B-4F43-8FB4-4747599B0C9A Q37621530-E63F1FD0-2916-426A-A823-25BB72CE5E3F Q37741310-BC38C1D3-A299-4930-9538-11969E4D77EF Q38184579-C1D68228-6DC1-4D3B-A76B-D844D25A0000 Q38210557-2FBF6A06-E447-4938-8130-EFF51D82BB73 Q38266429-3BCC4138-C362-4A5B-9AB3-5787267ED0B9 Q40042060-9D5037EC-54F5-47BF-81A0-9A45C735E72E Q40054175-E9986412-DA92-41B4-B21B-4AB9F468B160 Q40619713-06121695-710E-464E-B2F1-11F155E48D03 Q47112156-0A5AE5C5-A3C5-4CA7-AA1D-80074753B89C Q50043345-7025AAE3-5BF3-4E1B-B76E-8D921FD4180A

P2860

Development of replication-competent viral vectors for HIV vaccine delivery.

http://www.wikidata.org/entity/Q33694226

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Development of replication-competent viral vectors for HIV vaccine delivery.

@ast

Development of replication-competent viral vectors for HIV vaccine delivery.

@en

type

label

Development of replication-competent viral vectors for HIV vaccine delivery.

@ast

Development of replication-competent viral vectors for HIV vaccine delivery.

@en

prefLabel

Development of replication-competent viral vectors for HIV vaccine delivery.

@ast

Development of replication-competent viral vectors for HIV vaccine delivery.

@en

P1433

Q33694226-AE4E1198-D7B4-4F3E-859D-4BC3D374E8A6

P1476

Q33694226-C2D4EA67-D721-4A85-9D8F-9B62D8E0E794

P2093

Q33694226-0D166B9B-BF60-46EA-9A55-41B07F21B8C7

Q33694226-79E29E34-5AA0-4041-8A4F-F3D3D3C2C266

Q33694226-E8F67DFF-28AA-403F-8EF8-E1FC0E094D75

P2860

Q33694226-022824D7-6575-43AC-B0C9-1C827271B3A7

Q33694226-0451F619-5599-4821-BCB2-1CDD492E8EB9

Q33694226-0784F1F8-1CB2-4503-9943-7C81A8082634

Q33694226-0DA7D857-7E0F-4783-A5CA-99BFB1EC9F7A

Q33694226-0EB19A6F-693A-41D4-9E79-C7E98A9ADCFD

Q33694226-10CBC92F-A3C7-403A-84D4-10E75F328EE1

Q33694226-117508B6-9141-433B-83C3-1125A1567D07

Q33694226-15E2BBF1-6FC0-4527-8B9C-7BFCA445E59A

Q33694226-205E5E1A-24BA-481D-84F0-7D04A9BB3169

Q33694226-257D0CA5-5AB5-436E-8012-7C8AD0BB9EE4

P304

Q33694226-292E9643-1650-4782-9930-D5AB6AEB0504

P31

Q33694226-247DBB76-9146-4401-990E-23FA19D73508

P356

Q33694226-C397ED99-B300-4EF8-99AF-3A4443D9E40C

P433

Q33694226-BCE649C1-7D2C-4A41-BFF2-16D2A53F5D52

P478

Q33694226-EFFCE54E-0C67-4D90-A46D-640DB201595A

P577

Q33694226-343B6378-B86B-4F94-9A19-DCABC28500B3

P698

Q33694226-B3333403-BA4B-4300-AE95-C6105149CDC8

P932

Q33694226-CA237478-F2A2-4025-83C2-4D13E0B42FFE

P356

COH.0B013E328363D389

P1433

Current Opinion in HIV and AIDS

P1476

Development of replication-competent viral vectors for HIV vaccine delivery.

@en

P2093

C Richter King

http://www.w3.org/2001/XMLSchema#string

Christopher L Parks

http://www.w3.org/2001/XMLSchema#string

Louis J Picker

http://www.w3.org/2001/XMLSchema#string

P2860

Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice

Design and pre-clinical evaluation of a universal HIV-1 vaccine

A reflection on HIV/AIDS research after 25 years

A novel self-replicating chimeric lentivirus-like particle

Immunogenicity of seven new recombinant yellow fever viruses 17D expressing fragments of SIVmac239 Gag, Nef, and Vif in Indian rhesus macaques

Current Status of Veterinary Vaccines

Comparative Efficacies of Three Commercially Available Vaccines against West Nile Virus (WNV) in a Short-Duration Challenge Trial Involving an Equine WNV Encephalitis Model

Hybrid alphavirus-rhabdovirus propagating replicon particles are versatile and potent vaccine vectors

Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses

Recombinant Yellow Fever Vaccine Virus 17D Expressing Simian Immunodeficiency Virus SIVmac239 Gag Induces SIV-Specific CD8+ T-Cell Responses in Rhesus Macaques

P304

402-411

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/COH.0B013E328363D389

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23925000

http://www.w3.org/2001/XMLSchema#string

P932

4040527

http://www.w3.org/2001/XMLSchema#string